These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Introduction of new Tumor Marker Age Score in clinical practice: Validity evaluation for differentiation benign from malignant adnexal masses. Ladjević IL, Terzić M, Ladjević N, Dotlić J, Pilić I, Bila J, Knezević N, Milenković S, Maricić S, Arsenović N, Brndusić N, Nikolić B. Acta Chir Iugosl; 2012 Dec; 59(3):49-56. PubMed ID: 23654006 [Abstract] [Full Text] [Related]
13. The Use of Human Epididymis 4 and Cancer Antigen 125 Tumor Markers in the Benign or Malignant Differential Diagnosis of Pelvic or Adnexal Masses. Dolgun ZN, Kabaca C, Karateke A, İyibozkurt C, İnan C, Altıntaş AS, Karadağ C. Balkan Med J; 2017 Apr 05; 34(2):156-162. PubMed ID: 28418343 [Abstract] [Full Text] [Related]